Publications of Julia Sacher

Journal Article (73)

2010
Journal Article
Sacher, J., Wilson, A. A., Houle, S., Rusjan, P., Hassan, S., Bloomfield, P. M., … Meyer, J. H. (2010). Elevated brain monoamine oxidase A binding in early postpartum period. Archives of General Psychiatry, 67, 468–474.
Journal Article
Schroeter, M. L., Abdul-Khaliq, H., Sacher, J., Steiner, J., Blasig, I. E., & Müller, K. (2010). Mood disorders are glial disorders: Evidence from in vivo studies. Cardiovascular Psychiatry and Neurology, 2010. doi:10.1155/2010/780645
2009
Journal Article
Kasper, S., Sacher, J., Klein, N., Mossaheb, N., Attarbaschi-Steiner, T., Lanzenberger, R., … Dudczak, R. (2009). Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. International Clinical Psychopharmacology, 24, 119–125.
Journal Article
Meyer, J. H., Wilson, A. A., Sagrati, S., Miler, L., Rusjan, P., Bloomfield, P. M., … Houle, S. (2009). Brain monoamine oxidase a binding in major depressive disorder: Relationship to selective serotonin reuptake inhibitor treatment, recovery and recurrence. Archives of General Psychiatry, 66, 1304–1312.
2008
Journal Article
Sacher, J., Mossaheb, N., Spindelegger, C., Klein, N., Geiss-Granadia, T., Sauermann, R., … Kasper, S. (2008). Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology, 33, 1633–1641.
2007
Journal Article
Attarbaschi, T., Sacher, J., Geiss-Granadia, T., Klein, N., Mossaheb, N., Lanzenberger, R., … Tauscher, J. (2007). Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. Eur Neuropsychopharmacol, 17, 102–7.
Journal Article
Klein, N., Sacher, J., Geiss-Granadia, T., Mossaheb, N., Attarbaschi, T., Lanzenberger, R., … Kasper, S. (2007). Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. Psychopharmacology, 191, 333–9.
Journal Article
Lanzenberger, R., Mitterhauser, M., Spindelegger, C., Wadsak, W., Klein, N., Mien, L.-K., … Tauscher, J. (2007). Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry, 61, 1081–9.
Journal Article
Sacher, J., Asenbaum, S., Klein, N., Geiss-Granadia, T., Mossaheb, N., Poetzi, C., … Tauscher, J. (2007). Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand. Int J Neuropsychopharmacol, 10, 211–8.
2006
Journal Article
Klein, N., Sacher, J., Geiss-Granadia, T., Attarbaschi, T., Mossaheb, N., Lanzenberger, R., … Kasper, S. (2006). In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology, 188, 263–72.
2005
Journal Article
Sacher, J., Weigl, L., Werner, M., & Hohenegger, M. (2005). Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther., 31, 1032–41.
2004
Journal Article
Klein , N., Sacher, J., Wallner, H., Tauscher, J., & Kasper, S. (2004). Therapy of treatment resistant depression: Focus on the management of TRD with atypical antipsychotics. CNS Spectrums, 9, 823–832.
Journal Article
Werner, M., Sacher, J., & Hohenegger, M. (2004). Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol., 143, :715–24.

Book Chapter (2)

2021
Book Chapter
Zsido, R., & Sacher, J. (2021). Time to rethink the default settings in neuroscience: Hormonal transition periods as natural experiments and why sex matters. In U. Weber (Ed.), Fundamental questions: Gender dimensions in Max Planck research projects (pp. 27–42). Baden-Baden: Nomos.
2017
Book Chapter
Sacher, J. (2017). Die Rolle von hormonellen Übergangsphasen für Geschlechtsunterschiede in der psychischen Gesundheit. In K. Stengler (Ed.), Genderperspektiven in der Medizin (GPmed): Abstractband zur Tagungsreihe an der Universität Leipzig (pp. 64–65). Leipzig: Pöge.

Meeting Abstract (26)

2024
Meeting Abstract
Hoffmann, K. C., Zsido, R., Villringer, A., Engert, V., & Sacher, J. (2024). Stress markers and brain structure in premenstrual dysphoric disorder and health across the menstrual cycle. In Neuropsychopharmacology (Vol. 49, pp. 373–374). New York, NY: Springer Nature.
2023
Meeting Abstract
Endres, K., Lammer, L., Wittekind, D., Riedel-Heller, S. G., Sacher, J., Villringer, A., & Witte, A. V. (2023). Obesity and depressive symptoms: Investigating the mediating role of fasting ghrelin serum levels. In Neuroscience Applied (Vol. 2). Amsterdam, The Netherlands: Elsevier. doi:10.1016/j.nsa.2023.102798
2022
Meeting Abstract
Zsido, R., Williams, A. N., Barth, C., Serio, B., Kurth, L., Beyer, F., … Sacher, J. (2022). Menstrual cycle brain plasticity: Ultra-high field 7 T MRI reveals changes in human medial temporal lobe volume in female adults. In Neuropsychopharmacology (Vol. 47, pp. 241–242). New York, NY: Springer Nature.
2021
Meeting Abstract
Schaadt, G., Zsido, R., Friederici, A. D., Villringer, A., Obrig, H., Männel, C., & Sacher, J. (2021). Association of maternal mood postpartum with electroencephalography patterns of infant speech development at 2 and 6 months. In Neuropsychopharmacology (Vol. 46, pp. 144–145). New York, NY: Springer Nature.
Meeting Abstract
Beinhölzl, N., Molloy, E., Zsido, R., Richter, T., Piecha, F. A., Zheleva, G., … Sacher, J. (2021). One-week of escitalopram administration does not change emotional and attentional responses in healthy female individuals on oral hormonal contraceptives. In European Neuropsychopharmacology (Vol. 53, pp. S603–S604). Amsterdam: Elsevier.
Go to Editor View